|Introduced in House||Passed House||Introduced in Senate||Passed Senate||Became Law|
Requires pharmacist to complete additional training for consultant pharmacist licensure; authorizes consultant pharmacist to perform specified services; prohibits consultant pharmacist from modifying or discontinuing medicinal drugs prescribed by health care practitioner; requires maintenance of collaborative practice agreements; requires such agreements be available upon request by DOH; prohibits consultant pharmacist from diagnosing disease or condition.
|01/22/2020||House||Original reference(s) removed: Health Care Appropriations Subcommittee CS referred to Health and Human Services Committee -HJ 419 Now in Health and Human Services Committee -HJ 419 CS by Health Quality Subcommittee read 1st time -HJ 418|
|01/21/2020||House||CS by Health Quality Subcommittee; YEAS 14 NAYS 0 -HJ 421 Pending review of CS under Rule 7.18(c)|
|01/16/2020||House||On Committee agenda-- Health Quality Subcommittee, 01/21/20, 10:00 am, Mashburn Hall|
|01/14/2020||House||Introduced -HJ 49|
|11/25/2019||House||Referred to Health Quality Subcommittee; Health Care Appropriations Subcommittee; Health and Human Services Committee -HJ 49|